ABEO - Abeona Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABEO is currently covered by 6 analysts with an average price target of $51.49. This is a potential upside of $46.33 (897.87%) from yesterday's end of day stock price of $5.16.

Abeona Therapeutics's activity chart (see below) currently has 40 price targets and 54 ratings on display. The stock rating distribution of ABEO is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 29.9% with an average time for these price targets to be met of 140 days.

Highest price target for ABEO is $20, Lowest price target is $15, average price target is $18.8.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 12-Nov-2025. First documented stock forecast 06-Jan-2017.

Currently out of the existing stock ratings of ABEO, 11 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Apr-2025

$19

$14.15 (291.75%)

$21

3 months 25 days ago
(12-Nov-2025)

0/2 (0%)

$14.06 (284.62%)

Buy Since 16-Oct-2017

$20

$15.15 (312.37%)

$20

4 months 24 days ago
(13-Oct-2025)

0/10 (0%)

$14.59 (269.69%)

Buy Since 02-Jun-2025

$20

$15.15 (312.37%)

$19

6 months 22 days ago
(15-Aug-2025)

0/2 (0%)

$12.87 (180.50%)

Buy Since 30-May-2024

$20

$15.15 (312.37%)

$21

9 months 21 days ago
(16-May-2025)

0/2 (0%)

$13.9 (227.87%)

Buy Since 19-Feb-2025

$15

$10.15 (209.28%)

$15

11 months 13 days ago
(24-Mar-2025)

0/2 (0%)

$9.88 (192.97%)

Show more analysts

Please expand the browser size to see the chart

What is ABEO (Abeona Therapeutics) average time for price targets to be met?

On average it took 140 days on average for the stock forecasts to be realized with a an average price target met ratio 29.9

Which analyst has the current highest performing score on ABEO (Abeona Therapeutics) with a proven track record?

JASON MCCARTHY

Which analyst has the most public recommendations on ABEO (Abeona Therapeutics)?

Jason Mccarthy works at MAXIM GROUP and has 0 price targets and 0 ratings on ABEO

Which analyst is the currently most bullish on ABEO (Abeona Therapeutics)?

Vernon Bernardino with highest potential upside - $720.79

Which analyst is the currently most reserved on ABEO (Abeona Therapeutics)?

Maury Raycroft with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?